HOWARD H PIEN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HOWARD H PIEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HOWARD H PIEN. HOWARD H PIEN is Chairman & CEO in CHIRON CORP ($CHIR) and President & CEO in CHIRON CORP ($CHIR) and Director in IMMUNOGEN INC ($IMGN) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in Juno Therapeutics, Inc. ($JUNO) and in Sage Therapeutics, Inc. ($SAGE).
Latest Insider Trading Transactions of HOWARD H PIEN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CHIR, IDRA, IMGN, JUNO, SAGE, VNDA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 2.25 | 5,583 | 12,562 | 45,457 | 39.9 K to 45.5 K (+14.00 %) |
Jul 02 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 1.79 | 7,018 | 12,562 | 39,874 | 32.9 K to 39.9 K (+21.36 %) |
May 19 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Option Exercise | A | 1.97 | 11,500 | 22,655 | 11,500 | |
Apr 03 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 1.28 | 9,666 | 12,372 | 32,856 | 23.2 K to 32.9 K (+41.68 %) |
Jan 06 2020 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 1.85 | 6,790 | 12,562 | 23,190 | 16.4 K to 23.2 K (+41.40 %) |
Oct 02 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 2.67 | 4,610 | 12,309 | 16,400 | 11.8 K to 16.4 K (+39.10 %) |
Jul 02 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 2.61 | 4,469 | 11,664 | 11,790 | 7.3 K to 11.8 K (+61.04 %) |
Jul 02 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 2.61 | 4,469 | 11,664 | 11,790 | 7.3 K to 11.8 K (+61.04 %) |
Jun 06 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Option Exercise | A | 2.57 | 11,500 | 29,555 | 11,500 | |
Jan 03 2019 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Grant | A | 3.52 | 2,929 | 10,310 | 2,929 | 0 to 2.9 K |
Sep 20 2018 | IDRA | IDERA PHARMACEUTIC ... | PIEN HOWARD H | Director | Option Exercise | A | 7.99 | 23,000 | 183,770 | 23,000 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | D | 23.29 | 12,000 | 279,480 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | D | 42.40 | 12,000 | 508,800 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | D | 60.00 | 12,000 | 720,000 | 0 | |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Sell | D | 87.00 | 5,050 | 439,350 | 0 | 5.1 K to 0 (-100.00 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Sell | U | 87.00 | 111,587 | 9,708,069 | 5,050 | 116.6 K to 5.1 K (-95.67 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Gift | G | 0.00 | 1,162 | 0 | 116,637 | 117.8 K to 116.6 K (-0.99 %) |
Mar 07 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Gift | G | 0.00 | 12,251 | 0 | 117,799 | 130.1 K to 117.8 K (-9.42 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 417 | 0 | 130,050 | 129.6 K to 130.1 K (+0.32 %) |
Jan 09 2018 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Gift | G | 0.00 | 25,000 | 0 | 129,633 | 154.6 K to 129.6 K (-16.17 %) |
Jan 03 2018 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 1,033 | 0 | 78,298 | |
Oct 06 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 447 | 0 | 154,633 | 154.2 K to 154.6 K (+0.29 %) |
Oct 03 2017 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 882 | 0 | 77,265 | |
Jul 07 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 640 | 0 | 154,186 | 153.5 K to 154.2 K (+0.42 %) |
Jul 03 2017 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 949 | 0 | 76,383 | |
Jun 19 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | A | 23.29 | 12,000 | 279,480 | 12,000 | |
Jun 15 2017 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 4.64 | 10,000 | 46,400 | 10,000 | |
Jun 15 2017 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 75,434 | |
Apr 06 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 865 | 0 | 153,546 | 152.7 K to 153.5 K (+0.57 %) |
Apr 04 2017 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 1,744 | 0 | 72,434 | |
Jan 09 2017 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 995 | 0 | 152,681 | 151.7 K to 152.7 K (+0.66 %) |
Jan 03 2017 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 6,617 | 0 | 70,690 | |
Dec 13 2016 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 1.84 | 5,000 | 9,200 | 5,000 | |
Dec 13 2016 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 64,073 | |
Oct 17 2016 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 675 | 0 | 151,686 | 151 K to 151.7 K (+0.45 %) |
Oct 03 2016 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 5,037 | 0 | 62,573 | |
Jul 06 2016 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 4,383 | 0 | 57,536 | |
Jul 05 2016 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 505 | 0 | 151,011 | 150.5 K to 151 K (+0.34 %) |
Jun 24 2016 | SAGE | Sage Therapeutics, ... | PIEN HOWARD H | Option Exercise | A | 28.35 | 13,922 | 394,689 | 13,922 | ||
Jun 21 2016 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | A | 42.40 | 12,000 | 508,800 | 12,000 | |
Apr 07 2016 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Grant | A | 0.00 | 506 | 0 | 150,506 | 150 K to 150.5 K (+0.34 %) |
Apr 04 2016 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 1,584 | 0 | 53,153 | |
Jan 04 2016 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 994 | 0 | 51,569 | |
Nov 12 2015 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 13.07 | 10,000 | 130,700 | 10,000 | |
Nov 12 2015 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 3,000 | 0 | 50,575 | |
Oct 01 2015 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 1,406 | 0 | 47,575 | |
Jul 01 2015 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 938 | 0 | 46,169 | |
Jun 22 2015 | VNDA | Vanda Pharmaceutic ... | PIEN HOWARD H | Director | Option Exercise | A | 13.03 | 15,000 | 195,450 | 15,000 | |
Jun 16 2015 | JUNO | Juno Therapeutics, ... | PIEN HOWARD H | Director | Option Exercise | A | 60.00 | 12,000 | 720,000 | 12,000 | |
May 29 2015 | SAGE | Sage Therapeutics, ... | PIEN HOWARD H | Option Exercise | A | 73.13 | 13,922 | 1,018,116 | 13,922 | ||
Apr 02 2015 | IMGN | IMMUNOGEN INC | PIEN HOWARD H | Director | Option Exercise | A | 0.00 | 1,508 | 0 | 45,231 | |
Apr 19 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Option Exercise | D | 0.00 | 40,000 | 0 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Apr 19 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Option Exercise | D | 0.00 | 40,000 | 0 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Apr 19 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Option Exercise | D | 33.88 | 350,000 | 11,858,000 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Option Exercise | D | 37.90 | 480,000 | 18,189,600 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Option Exercise | D | 37.90 | 200,000 | 7,579,000 | 0 | |
Apr 19 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Sell | D | 48.00 | 27,319 | 1,311,312 | 0 | 27.3 K to 0 (-100.00 %) |
Apr 04 2006 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Payment of Exercise | F | 45.71 | 894 | 40,860 | 27,319 | 28.2 K to 27.3 K (-3.17 %) |
Apr 04 2005 | CHIR | CHIRON CORP | PIEN HOWARD H | Chairman & CEO | Payment of Exercise | F | 35.36 | 893 | 31,572 | 28,213 | 29.1 K to 28.2 K (-3.07 %) |
Apr 07 2004 | CHIR | CHIRON CORP | PIEN HOWARD H | President & CEO | Payment of Exercise | F | 44.33 | 894 | 39,631 | 29,106 | 30 K to 29.1 K (-2.98 %) |
Feb 17 2004 | CHIR | CHIRON CORP | PIEN HOWARD H | President & CEO | Option Exercise | A | 51.98 | 350,000 | 18,193,000 | 350,000 |
Page: 1